The effects of airway inflammation induced by chronic antigen exposure on substance P (SP)-induced increases and vasoactive intestinal peptide (VIP)-induced decreases in airway opening pressure (Pao), and the recovery of intact and hydrolyzed radiopeptide were studied in tracheally perfused guinea pig lungs. SP (10-6 mol/kg) induced a significantly greater increase in Pao in lungs from antigen-exposed (30±5 cm H20) than saline-exposed animals (15±1 cm H20, P < 0.05). Significantly more intact 3H-SP and significantly less 3H-SP 1-7, a neutral endopeptidase (NEP) hydrolysis product, were recovered from the lung effluent of antigen-exposed than saline-exposed animals (P < 0.05). Injection of VIP (10-' mol/kg) induced significantly more pulmonary relaxation in saline-exposed compared with antigen-exposed lungs (62±4%, P < 0.001). In contrast to effluent from saline-exposed animals, lung effluent from antigen-exposed lungs contained less intact VIP, increased amounts of a tryptic hydrolysis product, and no products consistent with the degradation of VIP by NEP. These data indicate that inflamed lungs are more sensitive to the contractile effects of SP because it is less efficiently degraded by NEP and are less sensitive to the relaxant effects of VIP because it is more efficiently degraded by a tryptic enzyme. Changes in airway protease activity occur with allergic inflammation and may contribute to airway hyperresponsiveness. (J. 
Introduction
Airway inflammation is now recognized as an important pathologic feature of asthma ( 1, 2) . However, the mechanisms linking inflammation to the episodic airway obstruction and airway hyperresponsiveness characteristic of asthma have not been established. One possible link between airway inflammation and deranged physiological function is altered enzymatic inactivation of neuropeptides (3) (4) (5) (6) . In particular, there is reason to believe that altered inactivation of two peptides impor-tant for regulating airway responses, substance P (SP)' and vasoactive intestinal peptide (VIP), could occur in the inflammatory microenvironment. Since the physiological effects of these peptides are known to be limited by enzymatic hydrolysis, it is possible that inflammation, by influencing the expression or activity of these enzymes, could alter hydrolytic inactivation of these peptides. SP is hydrolyzed and inactivated by neutral endopeptidase (NEP) (7-10) (E.C.3.4.24.1 1), while VIP is hydrolyzed and inactivated by NEP and a tryptic enzyme ( 11) . If in the inflammatory microenvironment NEP activity is diminished, the physiological effects of SP would be enhanced. However, the effects of inflammation on VIP activity will depend on alterations in both NEP and tryptic activity. To determine the importance of airway inflammation induced by chronic antigen exposure on the activity and enzymatic inactivation of SP and VIP, we examined the physiological effects, recovery of intact peptide, and recovery ofthe hydrolysis products of SP and VIP in normal and chronically inflamed guinea pig lungs. We found that lungs with chronic allergic inflammation were more sensitive to the contractile effects of SP and less sensitive to the relaxant effects of VIP than control lungs. In addition, the effects of enzyme inhibitors on physiological responses and peptide cleavage profiles were consistent with decreased NEP and enhanced tryptic activity.
Methods
Antigen exposure protocol. Airway inflammation was accomplished by ovalbumin exposure and sensitization modified from the method of Hutson et al. (12, 13) . Male Hartley guinea pigs, 300-350 g body weight, were pretreated with pyrilamine malate 10 mg/kg (doses are expressed per kg animal) given by intraperitoneal injection 10 min before each aerosol exposure; the pyrilamine prevented respiratory distress secondary to the release of histamine during the sensitization period. Animals were sensitized by exposure to aerosolized ovalbumin ( 1% wt/ vol in 0.9% sterile sodium chloride) or saline alone in an aerosol exposure chamber which exposed six animals simultaneously to a single aerosolized stream. Each animal had its snout fixed 15 cm from the point of aerosol entry in a chamber with a volume of 33 liters. Nebulization was accomplished by two Acorn 1 nebulizers (Marquest Medical Products Inc., Englewood, CO), which were powered by pressurized oxygen delivered at a flow rate of 8 liters/min. After a 3-min exposure period, the chamber was cleared of aerosol by vacuum suction through a filter apparatus and room air was provided to the animals. Animals were exposed on three occasions at 7-d intervals, and the lungs were harvested three days after the final exposure.
Histopathologic examination. Two groups of five male Hartley strain guinea pigs ( 330-4 10 g) repeatedly exposed to either antigen or saline aerosol as described above, were anesthetized with 65 mg sodium pentobarbital/kg given by intraperitoneal injection. When an appropriate plane of anesthesia was achieved, the abdominal cavity was opened and 500 U of heparin were injected into the vena cava. 3 min later the abdominal aorta was severed and the guinea pig was exsanguinated. The thoracic cavity was opened and a right ventricular catheter was placed. Karnovsky's fixative was infused into the catheter at 20 cm H20 pressure. After lung expansion and equilibration the heart-lung bloc was removed. The distal 1 cm of trachea was bisected longitudinally and a coronal section ofthe right lower lobe, including the proximal bronchovascular bundle were placed in Karnovsky's fixative overnight and stored at 4VC for at least 24 h in cacodylate buffer. Fixed tissues were embedded in glycolmethacrylate, sectioned, and stained with methylene blue and basic fuchsin.
The degree of airway inflammation was quantitated by a pulmonary pathologist blinded as to the exposure status of the animals from which the lungs were harvested. Histologic grading ofairway inflammation, from the trachea to the lobar bronchi, was accomplished by examining the airway epithelium at X400 and scoring the presence ofinflammatory cells semi-quantitatively as presented in Table I ( 12, 13) . The percentage of mast cells, in the trachea, demonstrating histologic evidence of degranulation was calculated from counts of all mast cells present in a six tracheal ring span ofcoronally cut trachea. In addition to the 10 lungs specifically prepared for histologic study, tracheal and parenchymal sections ofall tracheally perfused lungs were fixed in Karnovsky's fixative and subjected to histologic evaluation as described above.
Tracheally perfused lung preparation. Tracheal perfusion was performed as previously described (9, 11) : 112 male Hartley strain guinea pigs (57 saline-exposed and 55 antigen-exposed), (330-410 g) were anesthetized with 65 mgofsodium pentobarbital/kgby intraperitoneal injection. When an appropriate plane of anesthesia was achieved, a tracheostomy was created and a 2-cm length of polyethylene tubing (1.67 mm I.D., 2.42 mm O.D.) was placed in the trachea. The abdominal cavity was opened and 500 U ofheparin were injected into the vena cava. 3 min later the abdominal aorta was severed and the guinea pig was exsanguinated. The thoracic cavity was widely opened and the heart and lungs were removed en bloc. The lungs were dissected free and placed in a 37°C, 100% relative humidity PlexiglasP box. The lungs were tracheally perfused with a phosphate-buffered physiological solution whose composition was NaCl 137 mM, CaCl2 1.8 mM, MgCl2
1.05 mM, KCl 2.68 mM, NaHCO3 0.6 mM, NaH2PO4 0.13 mM, and Na2HPO4 0.896 mM, pH 7.4. The perfusion buffer was warmed to 45°C and pumped at 5 ml/min through a bubble trap before being cooled to 37°C and administered to the lungs through the tracheal cannula. Perfusate exited the fully expanded lungs via numerous small holes placed in the pleura. The "back pressure" resulting from tracheal perfusion (airway opening pressure, Pao) was recorded from a side tap at the tracheal cannula with the use of a pressure transducer (P23Db; Statham Instruments Inc., Oxnard, CA). We have previously shown that during continuous flow Pao reflects the contractile state ofthe lung (9, 11) . All experiments involving animals were approved by the appropriate animal care and use committees. Protocols for comparing SP and methacholine effects in inflamed and normal lungs Effects ofinflammation on SP-or methacholine-Pao dose-response relationship. SP was rapidly injected into the perfusion stream of tracheally perfused lungs harvested from antigen-exposed and saline-exposed animals, and the resulting increase in Pao was recorded. Pao responses were recorded for 10 groups of three lungs each (15 antigenexposed and 15 saline-exposed), injected with geometrically increasing doses of SP (3 X 10-8 to 3 X 10-6 mol/kg). A single measurement was obtained per lung. Pao responses were recorded for two groups of five lungs each (five antigen-exposed and five saline-exposed), injected with geometrically increasing doses of methacholine.
Effects ofNEP inhibition on SP-induced Pao responses in inflamed lungs. Pao was recorded after tracheal injection of 10-6 mol SP/kg in four groups offive tracheally perfused lungs. Two ofthese groups were antigen-exposed and two groups were saline-exposed. SCH 32,615 was dissolved in DMSO and diluted 1:10,000 into the perfusion buffer to yield a final concentration of 10-6 M. An equal amount of DMSO was added to the perfusion buffer of the groups that did not receive SCH 32,615.
Effects of inflammation on SP hydrolysis product profile. 3H-SP (10' dpm) and 3 X 10'-moles of nonradiolabeled SP was injected into the perfusion stream of three antigen-exposed tracheally perfused lungs and five saline-exposed lungs. Lung effluent was collected as previously described (9) ; the lung effluent fraction containing SP cleavage products (2.5-5 min after SP injection) was subjected to HPLC analysis as described below. Identification of3H-SP and 3H-SP hydrolysis products. Identification of potential SP cleavage products (i.e., SP 1-6, SP 1-7, and SP 1-9) was accomplished by comparing the reverse-phase HPLC retention times of synthetic SP and its peptide fragments to the retention times of 3H-radiolabel recovered from lung effluent. Reverse-phase HPLC separation was accomplished with the use ofa C18 reverse-phase column (Nova-Pak, 3.9 X 300 mm; Waters Instruments, Milford, MA) at a flow rate of 1 ml/min. The initial mobile phase was HPLC grade H20 with 0.1% trifluroacetic acid (TFA); the column was eluted with a 0.7% to 49% linear gradient of acetonitrile in HPLC grade H20 with 0.19% TFA > 40 min. The 3H content was determined by scintillation counting (Beckman Instruments Inc., Fullerton, CA) aliquots of HPLC effluent collected at 1-min intervals and suspended in scintillation counting solution (National Diagnostics, Mannville, NJ). Peptide loss to the column was < 5%.
Protocols for comparing the relaxant effects of VIP in inflamed and normal lungs Effects of inflammation on the relaxant response to VIP. During tracheal perfusion with 10-' M methacholine in the perfusion buffer, Pao rose slowly and reached a stable plateau between 13 and 18 min. In this setting tracheal injection of VIP or isoproterenol caused a rapid decrease in Pao; all data examining pulmonary relaxation are reported in lungs with methacholine-induced airway tone. VIP was rapidly injected into the perfusion stream oftracheally perfused lungs harvested from animals exposed to antigen or saline, and the resulting decrease in Pao was recorded. Two groups of five lungs each were exposed to geometrically increasing doses of VIP ( I0 -l°I0-7 mol/kg), and Pao responses were recorded. Two groups offive lungs each were also exposed to geometrically increasing doses of isoproterenol (I0 l 0 8 mol! kg), and the Pao response was recorded.
Effects ofinflammation on VIP recovery in lung effluent. After tracheal injection of 10-9 moles of VIP, a 5-min fraction of lung effluent was collected in 5% by volume glacial acetic acid, dried under vacuum and stored at -20'C. Recovery of VIP was quantified by an ELISA, which is insensitive to VIP hydrolysis products, as previously described ( 11).
Effects of inflammation on VIP hydrolysis product profile. After tracheal injection of 250,000 dpm of (mono ["25I] iodo-Tyr'0)-VIP and I0-9 mol of nonradiolabeled VIP, serial 1-min fractions of perfusate were recovered from lungs harvested from animals that had been exposed to antigen (n = 2), from lungs harvested from animals exposed to saline (n = 2), and from lungs treated with SBTI, 500 TIU/kg, harvested from animals exposed to antigen (n = 2). Samples were dried under vacuum, resuspended in 600 Ml of HPLC grade H20 with 0.1% (vol/vol) TFA, divided into two 300-Mul aliquots, passed through a 0.22-,gm filter (Millipore Corp., Medford, MA), and subjected to RP-HPLC analysis as described below. Recovery of radiolabel was > 90%.
Effects ofinflammation on inhibitor (SBTI) potentiation ofVIP-induced pulmonary relaxation. Pao was recorded after tracheal injection of l0-9 mol/kg VIP in four groups of five tracheally perfused lungs. Two of these groups were antigen-exposed and two were saline exposed. The "antigen-exposed + SBTI" and "saline-exposed + SBTI" groups had 500 TIU/kg SBTI added to their perfusion buffer. column (Nova-Pak*, 3.9 X 300 mm (Waters Instruments) at a flow rate of 1 ml/min. The initial mobile phase for both HPLC protocols was HPLC grade H20 with 0.1% TFA. In elution protocol 1, the column was eluted with a 0.7-49% linear gradient of acetonitrile over 40 min. In elution protocol 2, the column was eluted with a 14-49% linear gradient of acetonitrile over 55 min. 30-s fractions were collected, and 1251 content was determined by gamma counting (Packard, Sterling, VA). Authentic standards for all peptides were processed through the system without a lung present, yielding recoveries of 33-95%; radiochromatograms were corrected for the background activity and for losses due to processing. The inhibitor combinations used had no effect on the elution time of the VIP breakdown products. (Fig. 1) . The histologic grade of airway inflammation was 2.1±0.1 in antigen-exposed lungs, which was significantly greater than that ofsaline-exposed lungs (0.6±0.2; P < 0.001; n = 5). A histologic grade of > 2 indicated that inflammatory cells could be seen in nearly every field examined from the trachea to the lobar bronchi, while a grade < 1 indicated that few inflammatory cells were present. Tracheal sections and airways present in parenchymal sections of antigen-exposed, but not saline-exposed, animals demonstrated mucosal and submucosal infiltration most prominently with eosinophils, but neutrophils and occasional lymphocytes were also present. Abnormalities were not observed in the lung parenchyma. The percentage of mast cells demonstrating histologic evidence of degranulation was significantly greater in the tracheas of antigen exposed compared to saline exposed animals (44±14% compared to 9±8%, P < 0.001 ).
Effects ofinflammation on SP-Pao and methacholine doseresponse relationship. Antigen-exposed lungs were significantly more responsive to the contractile effects of SP at doses from 3 x I0-7to 3 X 10-6 mol/kg (P < 0.05, n = 3) than saline-exposed lungs, Fig. 2 . Antigen-exposed lungs were also significantly more responsive to the contractile effects of methacholine. The methacholine ED,0was 8.6±0.6 X 10-8 moles in antigen exposed lungs compared to 6.4±1.1 X 10-moles in saline exposed lungs (P < 0.01, n = 5).
Effects ofNEP inhibition on SP-induced Pao responses in inflamed lungs. Tracheal injection of 10-6 mol/kg SP into lungs from saline-exposed animals resulted in an increase in Pao of 15±1 cm H20 (n = 5). When the NEP inhibitor SCH 32,615 (10-6 M) was added to the perfusion buffer of lungs from saline-exposed animals, a significant potentiation of the contractile effects of SP was observed; Pao increased 41±5 cm H20 (P < 0.005 compared with no SCH 32,615, n = 5) (Fig.  3) . In lungs from antigen-exposed animals, Pao increased 30±5 cm H20 (n = 5) after tracheal injection of an identical amount of SP. This response was significantly greater than that observed in lungs from saline-exposed animals not treated with the NEP inhibitor (P < 0.05) but not significantly different from that oflungs from saline-exposed animals treated with the NEP inhibitor. In contrast, the NEP inhibitor did not affect the Pao response to SP in lungs from antigen-exposed animals. Pao increased 35±6 cm H20 in lungs from the antigen-exposed group treated with SCH 32,615; this response was not significantly different from that observed in lungs from antigen-exposed animals not treated with the NEP inhibitor (30±5 cm H20, P = NS. n = 5) or in lungs from the saline-exposed group treated with SCH 32,615. The Pao response in antigen-exposed animals was significantly greater than the Pao response in saline-exposed animals not treated with the NEP inhibitor (P < 0.05, Fig. 3 ). Effects of inflammation on SP hydrolysis product profile. Analysis of effluent collected from the lungs removed from saline-exposed animals after tracheal injection of 3H-SP revealed intact SP and SP fragments corresponding to NEP hydrolysis sites (i.e., SP 1-9, SP 1-7, and SP 1-6) (n = 5; Fig. 4 B) . In contrast, analysis ofeffluent collected from the lungs ofantigen-exposed animals after tracheal injection of 3H-SP revealed a significantly greater amount of intact SP and a lesser amount of the NEP hydrolysis product, SP 1-7 (P < 0.05, n = 3; Fig. 4 A) .
Effects of inflammation on the relaxant response to VIP. Lungs removed from antigen-exposed animals were resistant to the relaxant effects of VIP. Pao decreased 37±13% after tracheal injection of 10-10 mol/kg VIP and 62±4% after injection Substance P Dose (mol/kg) Figure 2 . SP-Pao dose-response relationships were measured in antigen-exposed and saline-exposed lungs. Tracheally perfused lungs from antigen-exposed animals (-) were significantly more sensitive to the contractile effects of SP than lungs from saline-exposed (o) animals (P < 0.05, n = 3).
of 10 -9 mol/ kg into the lungs ofsaline-exposed animals-each dose ofVIP resulted in a significant decrease in Pao, while there was no Pao effect from these doses in lungs from antigen-exposed animals (P < 0.05 for 10-10 mol/kg and P < 0.001 for 10-9 mol/kg, n = 5, Fig. 5 ). When 10-8 mol/kg VIP was administered, Pao decreased 48±13% in lungs from antigenexposed animals, while Pao decreased 89±5% in lungs from saline-exposed animals (P < 0.05, n = 5). There was no significant difference in the responsiveness of lungs from antigen-exposed and saline-exposed animals to the relaxant effects of isoproterenol (P = NS, n = 5, Fig. 5 ).
Effects ofinflammation on VIP recoveryfrom lung effluent.
After tracheal injection of 10-9 moles of VIP, significantly less unhydrolized VIP was detected in the effluent of antigen exposed compared to saline exposed lungs (65±17 pmol compared to 200±8 pmol, P < 0.001). 4t~s.o;7P~s°+Ssq075^-saline-exposed animals (n = 5, P < 0.05 for the saline-exposed group compared to all other groups). In contrast, SCH 32,615 had no significant effect in lungs from antigen-exposed animals (P = NS, n = 5). HPLC ELUTION TIME (min) Figure 4 . The recovery of intact 3H-SP and 3H-SP hydrolysis fragments was measured in lung effluent from antigen-exposed and saline-exposed animals. Recovery of intact 3H-SP in the lung effluent of antigen-exposed animals (A) was greater than the recovery from lung effluent of saline-exposed animals (B). The recovery of 3H-SP 1-7, a hydrolysis product of NEP activity, was less from effluent of lungs from antigen-exposed (n = 3) than saline-exposed animals (P < 0.05, n = 5).
Effects ofinflammation on VIP hydrolysis product profile.
There were fewer VIP hydrolysis products consistent with NEP activity in the effluent of tracheally perfused lungs removed from antigen-exposed compared with saline-exposed animals. 28% of the radiolabel coeluted with intact VIP 1-28 in the effluent of lungs from saline-exposed animals, while only 12% of the radiolabel coeluted with VIP 1-28 in the effluent from the lungs of antigen-exposed animals. In lung effluent from salineexposed animals, only 39% ofthe radiolabel coeluted with VIP 1-14, while 88% of the radiolabel administered to antigen-exposed lungs coeluted with this fragment of tryptic hydrolysis.
In lungs from saline-exposed animals, 33% of the radiolabel coeluted with VIP 4,5-14, a product ofcombined hydrolysis by NEP and a tryptic enzyme. In contrast, we were unable to identify VIP hydrolysis products consistent with NEP activity in the effluent of antigen-exposed lungs (Fig. 6 , representative data from single lungs). Examination of the VIP hydrolysis profile when SBTI was present in the perfusion buffer of lungs from antigen-exposed animals, reveals that more active, unhydrolized VIP and less inactive VIP 1-14 were recovered.
Effects ofinflammation on inhibitor (SBTI) potentiation of VIP-induced pulmonary relaxation. Tracheal injection of 10' mol/kg VIP into lungs of antigen-exposed animals resulted in a 3±2% decrease in Pao (P < 0.001 compared with all other groups, n = 5, Fig. 7 ). In the presence of SBTI, VIP relaxant activity was restored in lungs from antigen-exposed animals; Pao decreased by 57±2% in the "antigen-exposed + SBTI" group. Lungs from saline-exposed animals had a significant decrease in Pao after VIP injection. The Pao response to VIP injection was not altered by the presence of SBTI in saline-exposed lungs (Fig. 7) .
Discussion
It is now well established that the physiological effects of the neuropeptides are regulated by their enzymatic degradation in the pulmonary microenvironment (7) (8) (9) (10) (11) (15) (16) (17) . When SP is presented to the airway surface, its action is regulated predominantly by the activity ofNEP, while the physiological effects of VIP are regulated by NEP and a tryptic enzyme. In each case the degradative enzymes are positioned such that they are physiologically competitive with each other and the relevant receptors ( 18, 19) . It is also now well appreciated that the proteolytic capacity of the microenvironment can be altered by mediators of inflammation (20, 21 Figure 5 . The relaxant effects of VIP and isoproterenol were compared in lungs from antigen-exposed and salineexposed animals. Lungs from antigenexposed animals were less responsive to the relaxant effects of VIP than lungs from saline-exposed animals (n = 5, P < 0.05). In contrast, there was no significant difference in the relaxant response to isoproterenol in lungs from antigen-exposed compared with salineexposed animals (P = NS, n = 5).
Enzymatic Inactivation ofNeuropeptides in Inflamed Airways HPLC ELUTION TIME ( Figure 6 . VIP hydrolysis product profile was compared antigen-exposed and saline-exposed animals injected wi VIP hydrolysis products consistent with activity by NE] enzyme were recovered from the lung effluent of saline-( mals injected with '25I-VIP (A). In contrast, lung efflu gen-exposed animals (B) contained less intact VIP induced pulmonary relaxation in lungs from antigen-exposed animals (P < 0.001, n = 5 ) but had no significant effect in lungs from saline-exposed animals (P = NS, n = 5).
for regulating the airway contractile effects of SP when it is presented to the airway epithelial surface (9, 15, (22) (23) (24) (25) (26) rette smoke (28) , exposure to oxidants (20, 21, 29, 30) , and airway infection by viral (31 ) or mycoplasmal pathogens (32) .
To directly demonstrate that reduced NEP activity caused by antigen exposure resulted in decreased SP inactivation, we identified intact SP and its hydrolysis fragments in effluent from tracheally perfused lungs injected with 3H-SP. In control lungs we identified intact SP and SP fragments (SP 1-6, SP 1-7, SP 1-9; Fig. 4 resistance to the pulmonary relaxant effects of VIP in lungs from antigen-exposed animals is not a generalized inability to respond to inhibitory agonists, as isoproterenol-induced pulmonary relaxation was not altered (Fig. 5) . Instead, our data suggest that the decreased sensitivity to VIP is the result of increased degradation of this peptide, probably by a tryptic enzyme. It is now established that the physiological effects of VIP in this model of airway peptide delivery are limited by enzymatic inactivation in the microenvironment by NEP and a tryptic enzyme, which are equally important and physiologically competitive (11, 17, 33) . To determine which, if any, enzyme systems were altered by airway inflammation, we compared the quantity ofintact I25I-VIP and its radiolabeled hydrolysis fragments (VIP 1-14, VIP 4, 5-14) recovered from the effluent of lungs from antigen-or saline-exposed animals. The VIP cleavage product profile of saline-exposed lungs demonstrated VIP hydrolysis fragments consistent with inactivation by NEP and a tryptic enzyme and was similar to the profile we previously reported for normal lungs (Fig. 6 A) ( 1). In the effluent of lungs from antigen-exposed animals, no hydrolysis products consistent with NEP activity were recovered (Fig. 6  B) , thus providing further evidence of decreased NEP activity in inflamed lungs. Furthermore, less intact VIP 1-28 was recovered from the lung effluent of antigen-exposed than saline-exposed animals thereby supporting the hypothesis that antigenexposed, inflamed lungs degrade VIP in an abnormally efficient manner.
The effluent of lungs from antigen-exposed animals contained greater amounts of radiolabel that coeluted with VIP 1-14 than the effluent of saline-exposed lungs, an indication that these lungs possess enhanced activity of an enzyme that hydrolyses VIP at the 14-15 bond. We have previously shown that VIP 1-14 arises from proteolytic cleavage by a tryptic enzyme that can be inhibited by SBTI ( 11 ); this pattern of cleavage is what we would expect from the action of a rodent mast cell tryptase on VIP (34, 35) . Since the tryptic enzyme that inactivated VIP in normal lungs was sensitive to SBTI, we examined the effects of SBTI in lungs removed from animals repeatedly exposed to antigen and in control lungs. We confirmed our previous findings by demonstrating that SBTI had no effect on VIP-induced pulmonary relaxation in lungs from saline-exposed animals. In contrast, SBTI alone enhanced the relaxant response to VIP in lungs from antigen-exposed animals (Fig. 7 ) and was associated with enhanced recovery of active, unhydrolized VIP and diminished recovery of inactive VIP 1-14. These data implicate a tryptic enzyme as the primary modulator of VIP relaxant activity in inflamed lungs.
Antigen exposure is known to activate mast cells and liberate mast cell proteases into the extracellular microenvironment (36, 37). In this study, allergic inflammation was associated with histologic evidence of mast cell degranulation. The facts that the tryptic enzyme regulating VIP-induced relaxation had a hydrolysis profile for VIP identical to that of mast cell tryptase, was inhibited by inhibitors of serine proteases, and was strikingly more active in lungs removed from animals with evidence ofmast cell degranulation support the hypothesis that the enzyme regulating the physiological activity of VIP in inflamed lungs is a mast cell protease. It is possible that the failure of SBTI to augment VIP-induced pulmonary relaxation above that seen in untreated control lungs reflects the inability of SBTI to completely prevent VIP hydrolysis. It is also possible that the VIP binding activity of the VIP receptor is reduced by tryptic hydrolysis in inflamed lungs (38) . Our data do not allow us to distinguish between these possible mechanisms of impaired VIP effect.
Our data provide a possible mechanism for enhanced nonspecific airway responsiveness in inflamed lungs. We and others have previously shown that a variety of bronchoactive mediators release tachykinins from guinea pig lungs (39) (40) (41) (42) . Therefore, the loss of NEP activity observed in antigen-exposed lungs could result in an enhanced response to tachykinins released by other bronchoactive mediators. These data agree with the observation that enhanced methacholine (43) and antigen (44) responses in lungs of animals repeatedly exposed to antigen can be diminished by depletion of SP with capsaicin pretreatment. However, our data extend this mechanism by demonstrating that inflamed lungs are also resistant to the relaxant and likely homeostatic effects of VIP. Therefore, chronic inflammation modulates the microenvironment in two ways: it enhances the prophlogistic effects of peptides degraded by NEP, such as SP, while it diminishes the homeostatic effects ofVIP. Thus, through disruption ofthe balance between contractile and relaxant neuropeptides in the lung, inflammation can promote nonspecific airway hyperresponsiveness.
